anxiety impact and family burden
Related entities
Findings (27)
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5
None
improvementCombination treatment and sertraline were superior to placebo at week 12 on parent-reported anxiety impact and family burden, while CBT was not superior to placebo on anxiety impact but was on family
Effect: improvement; CAIS: COMB b=-7.7, t=-5.2; SRT b=-6.1, t=-4.0. BAS: COMB b=-10.3, t=-5.3; SRT b=-7.1, t=-3.5